# NSCLC Burden of Illness Study

> **NCT01772225** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1 (actual)

## Conditions studied

- Lung Cancer, Non-Small Cell

## Interventions

- **OTHER:** Data collection

## Key facts

- **NCT ID:** NCT01772225
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2014-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01772225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01772225, "NSCLC Burden of Illness Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01772225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*